These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8192279)

  • 1. Does a glycosylation defect of IgG reduce their binding to the corresponding receptors?
    Adler Y; Casburn-Budd R; Lamour A; Shoenfeld Y; Youinou P
    Ann Med Interne (Paris); 1994; 145(1):32-5. PubMed ID: 8192279
    [No Abstract]   [Full Text] [Related]  

  • 2. Divergent immunoglobulin g subclass activity through selective Fc receptor binding.
    Nimmerjahn F; Ravetch JV
    Science; 2005 Dec; 310(5753):1510-2. PubMed ID: 16322460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The difference of binding epitopes on human CD16 (FcgammaRIII) interacted with hIgG1 and monoclonal antibody B88-9.
    Feng J; Xie Z; Yu M; Guo N; Shen B
    Mol Immunol; 2004 May; 41(1):93-8. PubMed ID: 15140580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
    Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fc gamma receptors. Properties and participation in IgG binding and other biological processes].
    Sokal I
    Postepy Hig Med Dosw; 1995; 49(1):47-51. PubMed ID: 8657617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant soluble human Fcgamma receptor I with picomolar affinity for immunoglobulin G.
    Paetz A; Sack M; Thepen T; Tur MK; Bruell D; Finnern R; Fischer R; Barth S
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1811-7. PubMed ID: 16289041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
    Mota G; Moldovan I; Calugaru A; Hirt M; Kozma E; Galatiuc C; Brasoveanu L; Boltz-Nitulescu G
    Scand J Immunol; 2004 Mar; 59(3):278-84. PubMed ID: 15030579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pyogenes and phagocytic killing.
    von Pawel-Rammingen U; Johansson BP; Tapper H; Björck L
    Nat Med; 2002 Oct; 8(10):1044-5; author reply 1045-6. PubMed ID: 12357219
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly discovered Fc receptor that explains IgG-isotype disparities in effector responses.
    Bolland S
    Immunity; 2005 Jul; 23(1):2-4. PubMed ID: 16039573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
    White DM; Jensen MA; Shi X; Qu Zx ; Arnason BG
    Protein Expr Purif; 2001 Apr; 21(3):446-55. PubMed ID: 11281720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice.
    Kao D; Lux A; Schaffert A; Lang R; Altmann F; Nimmerjahn F
    Eur J Immunol; 2017 Dec; 47(12):2070-2079. PubMed ID: 28771702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
    de Haas M; Koene HR; Kleijer M; de Vries E; Simsek S; van Tol MJ; Roos D; von dem Borne AE
    J Immunol; 1996 Apr; 156(8):2948-55. PubMed ID: 8609432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Review article.
    Jefferis R; Pound J; Lund J; Goodall M
    Ann Biol Clin (Paris); 1994; 52(1):57-65. PubMed ID: 8210076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies.
    Nechansky A; Schuster M; Jost W; Siegl P; Wiederkum S; Gorr G; Kircheis R
    Mol Immunol; 2007 Mar; 44(7):1815-7. PubMed ID: 17011625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
    Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
    J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocortin 1 binding to human leukocytes correlates with its ability to inhibit IgG interactions with Fc gamma receptors.
    Goulding NJ; Guyre PM
    Biochem Biophys Res Commun; 1993 Apr; 192(2):351-8. PubMed ID: 8484747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the linear epitope for Fc-binding on the bovine IgG2 Fc receptor (boFcgamma2R) using synthetic peptides.
    Zhang G; Guo J; Zhou J; Wang X; Li Q; Yang Y; Shen H; Zhao D; Zhang H; Xi J; Wang L; Qiao S; Jin X
    FEBS Lett; 2006 Feb; 580(5):1383-90. PubMed ID: 16457820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity.
    Drescher B; Witte T; Schmidt RE
    Immunology; 2003 Nov; 110(3):335-40. PubMed ID: 14632661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the soluble, truncated form of an Fc receptor (mouse Fc gamma RII) to membrane-bound IgG as measured by total internal reflection fluorescence microscopy.
    Gesty-Palmer D; Thompson NL
    J Mol Recognit; 1997; 10(2):63-72. PubMed ID: 9376129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.